StayHappi Trimetazidine 35mg Tablet
Prescription Required
Product introduction
StayHappi Trimetazidine 35mg Tablet is an anti-anginal medicine used for treating heart-related chest pain (angina). It prevents new attacks of angina but does not stop an acute attack once it has started. It can be used alone or in combination with some other medicines.
StayHappi Trimetazidine 35mg Tablet is a medicine used for treating heart-related chest pain (angina) caused due to narrowing of blood vessels of the heart. It effectively prevents new attacks of angina but does not stop an acute attack once it has started. This medicine should be used along with lifestyle changes like healthy diet, regular exercise, and smoking cessation for best results. It is used as an add-on therapy for patients who are not relieved by or are intolerant to the initial medicines. It should not be stopped abruptly. Headache, vomiting, and dizziness may be seen as side effects.
StayHappi Trimetazidine 35mg Tablet is a medicine used for treating heart-related chest pain (angina) caused due to narrowing of blood vessels of the heart. It effectively prevents new attacks of angina but does not stop an acute attack once it has started. This medicine should be used along with lifestyle changes like healthy diet, regular exercise, and smoking cessation for best results. It is used as an add-on therapy for patients who are not relieved by or are intolerant to the initial medicines. It should not be stopped abruptly. Headache, vomiting, and dizziness may be seen as side effects.
Uses of StayHappi Tablet
Benefits of StayHappi Tablet
In Treatment of Angina (heart-related chest pain)
Angina is chest pain or discomfort that happens when there is not enough oxygen-rich blood going to part of your heart. This can occur when the blood vessels of the heart become narrow. By preserving energy metabolism in cells exposed to reduced oxygen supply, StayHappi Trimetazidine 35mg Tablet prevents a decrease in intracellular energy levels, thereby ensuring the proper functioning of heart muscle cells. StayHappi Trimetazidine 35mg Tablet can also help increase your ability to exercise and lead your daily life more easily by reducing the frequency of angina attacks. You should take it regularly and as long as it is prescribed for it to work effectively.
Research shows that the frequency of angina attacks reduces significantly after 6 months of treatment with StayHappi Trimetazidine 35mg Tablet.
Research shows that the frequency of angina attacks reduces significantly after 6 months of treatment with StayHappi Trimetazidine 35mg Tablet.
Side effects of StayHappi Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of StayHappi
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use StayHappi Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. StayHappi Trimetazidine 35mg Tablet is to be taken with food.
How StayHappi Tablet works
StayHappi Trimetazidine 35mg Tablet is an anti-anginal medication. It decreases the oxygen requirement of the heart by shifting its metabolism from fats to glucose. As a result, the heart works more efficiently.
Safety advice
Alcohol
UNSAFE
StayHappi Trimetazidine 35mg Tablet may cause excessive drowsiness with alcohol.
Pregnancy
CONSULT YOUR DOCTOR
Information regarding the use of StayHappi Trimetazidine 35mg Tablet during pregnancy is not available. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of StayHappi Trimetazidine 35mg Tablet during breastfeeding is not available. Please consult your doctor.
Driving
UNSAFE
StayHappi Trimetazidine 35mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
StayHappi Trimetazidine 35mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of StayHappi Trimetazidine 35mg Tablet may be needed. Please consult your doctor.
Use of StayHappi Trimetazidine 35mg Tablet is not recommended in patients with severe kidney disease.
Use of StayHappi Trimetazidine 35mg Tablet is not recommended in patients with severe kidney disease.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of StayHappi Trimetazidine 35mg Tablet in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
StayHappi Trimetazidine 35mg Tablet
₹4.2/Tablet
Trimacontin 35 Tablet
Modi Mundi Pharma Pvt Ltd
₹16.6/tablet
295% costlier
Aximeta 35mg Tablet
Axis Life Science Pvt Ltd
₹9.5/tablet
126% costlier
Carvidon 35mg Tablet
Micro Labs Ltd
₹7.5/tablet
79% costlier
Truemezidine 35mg Tablet
Truecure Healthcare Private Limited
₹12.9/tablet
207% costlier
Trimestar 35mg Tablet
Prevego Healthcare & Research Private Limited
₹12.7/tablet
202% costlier
Quick tips
- StayHappi Trimetazidine 35mg Tablet prevents new attacks of angina but does not stop an acute attack.
- Does not affect heart rate, blood pressure at rest or during exercise.
- Improves HbA1c and blood sugar levels in diabetes patients.
- Avoid driving or using machinery if you feel dizzy after taking StayHappi Trimetazidine 35mg Tablet.
Fact Box
Chemical Class
Phenylmethylamines
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Fatty acid modulator & Sodium channel blocker
Patient concerns
FAQs
Q. Is StayHappi Trimetazidine 35mg Tablet a beta blocker?
No, StayHappi Trimetazidine 35mg Tablet is not a beta blocker. It is an anti-anginal medicine which is used in combination with other medicines to treat angina pectoris (chest pain caused by coronary disease). It protects the heart cells from getting affected by the reduced oxygen supply during an episode of angina.
Q. Who should not take StayHappi Trimetazidine 35mg Tablet?
You should not take StayHappi Trimetazidine 35mg Tablet if you are allergic to it or have severe kidney problems. Patients with Parkinson’s disease should also avoid taking StayHappi Trimetazidine 35mg Tablet. Parkinson’s disease is a disease of the brain which affects movement and causes trembling, rigid posture, slow movements and a shuffling, unbalanced walk.
Q. Can StayHappi Trimetazidine 35mg Tablet be used in elderly patients?
StayHappi Trimetazidine 35mg Tablet should be used with caution in patients aged more than 75 years of age. Usually, a lower dose is prescribed in elderly patients to reduce the chances of adverse effects. It is important to continuously monitor such patients.
Q. Does taking StayHappi Trimetazidine 35mg Tablet increases the risk of falling down frequently?
Though it is rare, falls may occur with use of StayHappi Trimetazidine 35mg Tablet. This may be due to instability while walking or fall in blood pressure while standing up. The risk may be higher in elderly patients. Therefore, they need to be more careful and should be monitored.
Q. Does StayHappi Trimetazidine 35mg Tablet cause drowsiness?
Yes, StayHappi Trimetazidine 35mg Tablet may make you feel dizzy and drowsy. Therefore, you should avoid driving or using heavy machinery in case it causes these side effects.
Q. How should StayHappi Trimetazidine 35mg Tablet be taken?
You should take StayHappi Trimetazidine 35mg Tablet exactly as prescribed by your doctor. It is meant for oral use. So, take the tablets with sufficient amount of liquid, e.g. a glass of water. You can take this medicine with or without food.
Q. What are the possible side effects of StayHappi Trimetazidine 35mg Tablet?
The common side effects of StayHappi Trimetazidine 35mg Tablet include dizziness, headache, abdominal pain, diarrhea, indigestion, and hives, rash and itching. Its use may also make you feel sick and weak. The rare side effects may include fast or irregular heartbeats (also called palpitations), fall in blood pressure on standing which can further cause dizziness, lightheadedness or fainting, fall, and flushing.
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Trimetazidine dihydrochloride. Suresnes Cedex, France: Les Laboratoires Servier; 2001 [revised 27 Mar. 2007]. [Accessed 20 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 19 Mar. 2019] (online) Available from:
- CiplaMed. Trimetazidine dihydrochloride [Prescribing Information]. [Accessed 07 Aug. 2023]. (online) Available from:
- Trimetazidine dihydrochloride [Package leaflet: Information for the user]. Gidy, France: Les Laboratoires Servier Industrie; 2021. [Accessed 07 Aug. 2023]. (online) Available from:
- Ciapponi A, Pizarro R, Harrison J. WITHDRAWN: Trimetazidine for stable angina. Cochrane Database Syst Rev. 2017 Mar 20;3(3):CD003614. [Accessed 07 Aug. 2023]. (online) Available from:
Marketer details
Name: Sarvagunaushdhi Pvt Ltd
Address: 13Th Floor, Pearl Best Hight-1, Netaji Subhash Place, Pitampura, Delhi North Delhi DL 110034 IN
Country of origin: India
Lab tests offered by us
Related/Popular tests
12 people viewed this recentlyMRP
₹42
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me